BRENTUXIMAB VEDOTIN

UNII:	7XL5ISS668
Formula:
Preferred Substance Name:	BRENTUXIMAB VEDOTIN
GSRS Full Record:	7XL5ISS668 i

914088-09-8
ADCETRIS
BRENTUXIMAB [VANDF]
BRENTUXIMAB VEDOTIN (GENETICAL RECOMBINATION)
BRENTUXIMAB VEDOTIN [INN]
BRENTUXIMAB VEDOTIN [JAN]
BRENTUXIMAB VEDOTIN [MART.]
BRENTUXIMAB VEDOTIN [MI]
BRENTUXIMAB VEDOTIN [PURPLE BOOK CDER]
BRENTUXIMAB VEDOTIN [USAN]
BRENTUXIMAB VEDOTIN [VANDF]
BRENTUXIMAB VEDOTIN [WHO-DD]
CAC10-1006(4)
CAC10-VCMMAE
CAC10-VCMMAE(4)
CHIMERIC IGG1 CAC10 COVALENTLY LINKED TO THE CYTOTOXIC MOLECULE SGD-1010 VIA A PEPTIDE LINKER
MAB CHIMERIC (IGG1) ANTI P28908 (TNR8_HUMAN) (SGN-35)
SGN-35

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

BRENTUXIMAB VEDOTIN

Synonyms and Mappings

Resources